Skip to main content
FDC Ltd. logo

FDC Ltd. — Investor Relations & Filings

Ticker · FDC ISIN · INE258B01022 LEI · 3358009DDF52LHZHHA78 BSE.NS Manufacturing
Open in API
Filings indexed 659 across all filing types
Latest filing 2026-05-18 Regulatory Filings
Country IN India
Listing BSE.NS FDC

About FDC Ltd.

https://www.fdcindia.com

FDC Ltd. specializes in the manufacture and marketing of active ingredients and finished dosage forms. The company maintains a diverse portfolio across therapeutic segments, including anti-infectives, gastrointestinals, ophthalmics, and vitamins. It is widely recognized for its leadership in the oral rehydration salts (ORS) market with its flagship brand, Electral. Other notable products include Zifi, a broad-spectrum antibiotic, and Enerzal, a balanced energy drink. The organization operates multiple manufacturing facilities certified by global regulatory bodies and serves a broad range of markets. The company focuses on research and development to enhance its formulation capabilities and expand its footprint through strategic exports and partnerships.

Recent filings

Filing Released Lang Actions
FDC Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2026 ,inter alia, to consider and approve Intimation of Board Meeting to be held ....
Regulatory Filings Classification · 85% confidence The document is an official intimation to stock exchanges of a board meeting date under SEBI Listing Regulations, to consider and approve audited financial results. It is a regulatory announcement rather than the actual results or management discussion, and does not involve a change in board composition or report publication notice. Therefore, it falls under general Regulatory Filings (RNS).
2026-05-18 English
Announcement under Regulation 30 - ANDA approval
Regulatory Filings Classification · 91% confidence The document is a stock exchange notification under SEBI Listing Regulations informing investors of ANDA approval by the US FDA. It contains no financial statements, management changes, or report attachments—just a compliance announcement. This falls under general regulatory disclosures.
2026-05-18 English
General Updates
Regulatory Filings Classification · 90% confidence The document is an SEBI Listing Regulations (Regulation 30) intimation to stock exchanges regarding ANDA approval. It is a regulatory disclosure/announcement required under listing rules, not a financial report, management discussion, or other category. It falls into the general regulatory filings category (RNS).
2026-05-18 English
Copy of Newspaper Publication
Regulatory Filings Classification · 85% confidence The document is a compliance disclosure under Regulation 30 of SEBI LODR, submitting copies of a newspaper advertisement regarding a special share re-lodgement window and unclaimed dividend claim campaign. It is not a financial report, management presentation, dividend notice, or any specific category, but a routine regulatory announcement. It therefore falls under the general Regulatory Filings (RNS) category.
2026-05-13 English
Copy of Newspaper Publication
Proxy Solicitation & Information Statement Classification · 85% confidence The document is a SEBI LODR Reg.30 disclosure enclosing newspaper advertisements for a corrigendum to the Postal Ballot Notice dated April 21, 2026. A postal ballot notice (and its corrigendum) falls under proxy materials sent to shareholders to solicit votes on corporate resolutions. Therefore, it should be classified as a Proxy Solicitation & Information Statement.
2026-05-13 English
Information regarding the Notice of the opening of a special window for re-lodgment of the transfer requests of physical shares and for claiming of unclaimed dividend under the " Saksham ....
Regulatory Filings Classification · 87% confidence The document is a stock exchange disclosure under Regulation 30 of SEBI LODR notifying the attachment of newspaper advertisements. It does not contain or present financial statements or management discussion; nor is it an annual/interim report, earnings release, or proxy statement. It is a general regulatory announcement to the exchanges. Therefore, it falls under the fallback category “Regulatory Filings (RNS)”.
2026-05-13 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.